Status:
COMPLETED
Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles
Lead Sponsor:
University Magna Graecia
Conditions:
Infertility
Polycystic Ovary Syndrome (PCOS)
Eligibility:
FEMALE
18-35 years
Phase:
PHASE4
Brief Summary
The use of metformin pre-treatment and co-administration was recently proposed in infertile women affected by polycystic ovary syndrome (PCOS) treated with gonadotropins. Data from meta-analyses show...
Detailed Description
Infertile young non-obese insulin-resistant patients with PCOS who had a background of the first IVF treatment cycle cancelled because of high risk for OHSS will be enrolled and randomized in two trea...
Eligibility Criteria
Inclusion
- History of one previous cancelled cycle for high-risk of OHSS, or history of moderate/severe OHSS during their previous IVF cycle
- Infertility
- Polycystic ovary syndrome (PCOS)
- insulin resistance
- hyperandrogenism
Exclusion
- BMI\>30 kg/m2
- age \>35 years
- FSH\>9UI/L
Key Trial Info
Start Date :
May 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT01233206
Start Date
May 1 2009
End Date
January 1 2011
Last Update
June 10 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pugliese" Hospital
Catanzaro, Italy, 88100